RNA pull-down assays have made it possible to understand the lncRNA–protein networks present in different malignancies, for instance, BC-IMPAD in lung cancer, NEAT1/miR-17-5p/TGFβR2 in gastric cancer, and FENDRR-GSTP1 in colorectal cancer [56]. This evidence concerns the gene NEAT1 and breast cancer.